Weber, Michael A; Schmieder, Roland E; Kandzari, David E; Townsend, Raymond R; Mahfoud, Felix; Tsioufis, Konstantinos; Kario, Kazuomi; Pocock, Stuart; Tatakis, Fotis; Ewen, Sebastian; +11 more... Choi, James W; East, Cara; Lee, David P; Ma, Adrian; Cohen, Debbie L; Wilensky, Robert; Devireddy, Chandan M; Lea, Janice P; Schmid, Axel; Fahy, Martin; Böhm, Michael; (2022) Hypertension urgencies in the SPYRAL HTN-OFF MED Pivotal trial. Clinical Research in Cardiology, 111 (11). pp. 1269-1275. ISSN 1861-0684 DOI: https://doi.org/10.1007/s00392-022-02064-5
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Abstract
The SPYRAL HTN-OFF MED Pivotal trial ( https://clinicaltrials.gov/ct2/show/NCT02439749 ) demonstrated significant reductions in blood pressure (BP) after renal denervation (RDN) compared to sham control in the absence of anti-hypertensive medications. Prior to the 3-month primary endpoint, medications were immediately reinstated for patients who met escape criteria defined as office systolic BP (SBP) ≥ 180 mmHg or other safety concerns. Our objective was to compare the rate of hypertensive urgencies in RDN vs. sham control patients. Patients were enrolled with office SBP ≥ 150 and < 180 mmHg, office diastolic BP (DBP) ≥ 90 mmHg and mean 24 h SBP ≥ 140 and < 170 mmHg. Patients had been required to discontinue any anti-hypertensive medications and were randomized 1:1 to RDN or sham control. In this post-hoc analysis, cumulative incidence curves with Kaplan-Meier estimates of rate of patients meeting escape criteria were generated for RDN and sham control patients. There were 16 RDN (9.6%) and 28 sham control patients (17.0%) who met escape criteria between baseline and 3 months. There was a significantly higher rate of sham control patients meeting escape criteria compared to RDN for all escape patients (p = 0.032), as well as for patients with a hypertensive urgency with office SBP ≥ 180 mmHg (p = 0.046). Rate of escape was similar between RDN and sham control for patients without a measured BP exceeding 180 mmHg (p = 0.32). In the SPYRAL HTN-OFF MED Pivotal trial, RDN patients were less likely to experience hypertensive urgencies that required immediate use of anti-hypertensive medications compared to sham control.
Item Type | Article |
---|---|
Faculty and Department | Faculty of Epidemiology and Population Health > Dept of Medical Statistics |
PubMed ID | 35852582 |
Elements ID | 181835 |
Download
Filename: Weber_etal_2022_Hypertension-urgencies-in-the-spyral.pdf
Licence: Creative Commons: Attribution 4.0
Download